OptiBiotix Health has kicked off with its SlimBiome and LPLDL products at Supply Side West in Las Vegas, in late September 2017.
According to the company, the exhibition provided the opportunity to connect with 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries. The event also created the opportunity to meet with senior executives from existing corporate partners and potential new corporate partners, as well as distributors from Europe, the USA and Asia.
OptiBiotix Health recently got FDA registration for both of its product ranges, enabling it to present its products to food, beverage, consumer healthcare and pharmaceutical partners for distribution and sale into the US market.
Stephen O’Hara, CEO of OptiBiotix, believes this reflects the high level of confidence in the commercial potential of the company’s products. “As we build the range of applications and geographic scope of LPLDL and SlimBiome with new manufacturing and distribution partners; the scale of the opportunity enlarges allowing us to fully exploit the revenue generating potential of our products. If successful, this low risk, low cost approach to accessing multiple consumer healthcare and pharmaceutical markets around the world with multiple products has the potential to cumulatively generate substantive revenues in the forthcoming years across all platforms.”